FDA Approves the MED-EL Synchrony EAS Hearing Implant System

News The implant system combines two technologies: The Synchrony cochlear implant that stimulates the auditory nerve for high-frequency hearing loss, and the Sonnet EAS audio processor, with built-in acoustic amplification for low-frequency hearing loss. Contributed Author:  MED-EL USA Topics:  Implantables